The Impact of Arts-Based Interventions on Patient Hospital Experience

High Risk Pregnancy Clinical Trial

Official title:

The Impact of Arts-Based Interventions on Patient Hospital Experience for Patients on a High-Risk Obstetrics and Bone Transplant Units

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT04024670
• Other study ID #: IRB-300001347
• Status: Enrolling by invitation
• Phase: N/A
• Start date: January 1, 2019
• Est. completion date: July 1, 2024

Study information

• Verified date: December 2023
• Source: University of Alabama at Birmingham
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

nuts and bolts

Description:

interventions and timing of interventions

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 100
• Est. completion date: July 1, 2024
• Est. primary completion date: August 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion:

• Inpatient on either Bone Marrow Transplant ICU or High Risk Obstetrics Unit
• Estimated length of stay 2 or more weeks
• Age >18
• Patients who will potentially benefit from the AIM experience

Additional Inclusion Criteria:

• For the High Risk Obstetrics Unit group (hand-sewing), patients should be physically able to participate in hand-sewing activity.
• For the Bone Marrow Transplant IUC group (story-telling/poetry), patients should be physically able to participate in story-telling/poetry activity.

Exclusion:

• Patient too ill
• Complex medical condition that requires therapies which would not allow time for participation
• Declined to participate
• Age <18

Related Conditions & MeSH terms

• Bone Marrow
• High Risk Pregnancy

Intervention

Other:
• Arts Intervention
If selected for the arts activity, an artist in residence will visit you 3 times a week for a total of 3 weeks during your hospital stay. Two visits will focus on the arts activity and one visit will be the administration of the questionnaire. Each visit will be approximately 25 minutes at a time.

Locations

Country	Name	City	State
United States	University of Alabama at Birmingham	Birmingham	Alabama

Sponsors (1)

Lead Sponsor	Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate patient experience during the course of intervention using name of survey	define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best	Baseline at admissions
Primary	Evaluate patient experience during the course of intervention using name of survey	define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best	Baseline - end of week 1
Primary	Evaluate patient experience during the course of intervention using name of survey	define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best	week 1- week 2
Primary	Evaluate patient experience during the course of intervention using name of survey	define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best	week 2 - week 3
Primary	Evaluate patient experience during the course of intervention using name of survey	define survey - evaluate experiences, range of survey - explain likert scale 0-10 with 0 being x (allows patient to rate how much they disagree or agree with a statement), 0 being the worst outcome and 10 being the best	week 3 - weekly up to 10 weeks